Fasting Blood Glucose Linked to Mortality Outcomes in Patients With COVID-19
Researchers assessed the relationship between fasting blood glucose levels and the risk of mortality in patients hospitalized with COVID-19.
Researchers assessed the relationship between fasting blood glucose levels and the risk of mortality in patients hospitalized with COVID-19.
Hormone replacement therapy use is associated with reduced odds of all-cause mortality among women with a recorded diagnosis of COVID-19.
Investigators assessed the effects of androgen suppression therapy with degarelix on clinical outcomes among older men hospitalized with COVID-19 infection.
People with diabetes are at a higher risk of experiencing poor outcomes after contracting COVID-19, including hospitalization and death. Researchers expanded on a previous analysis to identify risk factors for short-term adverse outcomes among veterans with diabetes and COVID-19.
COVID-19 can cause additional complications and even death in people with a pre-existing conditions like type 2 diabetes. Researchers studied whether the medications people with type 2 diabetes often take were associated with a risk of dying from the virus.
Researchers conducted a study to determine whether integrase strand transfer inhibitor-based antiretroviral therapy is associated with lipid changes in patients with HIV infection.
Researchers sought to identify which medications for type 2 diabetes may be associated with severity of COVID-19.
Admission-blood glucose is strong predictor of death among patients admitted directly to the intensive care unit.
Patients with hyperglycemia and COVID-19 had higher cumulative probability of mortality.
Study authors assess the association between statin therapy and in-hospital mortality in patients with COVID-19 and concomitant diabetes mellitus.